Growth Metrics

Sangamo Therapeutics (SGMO) Amortizatization of Intangibles (2016 - 2025)

Sangamo Therapeutics (SGMO) has disclosed Amortizatization of Intangibles for 16 consecutive years, with $3.6 million as the latest value for Q4 2025.

  • For Q4 2025, Amortizatization of Intangibles fell 8.54% year-over-year to $3.6 million; the TTM value through Dec 2025 reached $3.6 million, down 14.41%, while the annual FY2025 figure was $3.6 million, 14.41% down from the prior year.
  • Amortizatization of Intangibles hit $3.6 million in Q4 2025 for Sangamo Therapeutics, up from -$1.8 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $6.6 million in Q3 2022 and bottomed at -$5.1 million in Q4 2022.
  • Average Amortizatization of Intangibles over 5 years is $453789.5, with a median of -$43000.0 recorded in 2022.
  • Year-over-year, Amortizatization of Intangibles plummeted 1036.67% in 2022 and then skyrocketed 4579.07% in 2023.
  • Sangamo Therapeutics' Amortizatization of Intangibles stood at -$450000.0 in 2021, then tumbled by 1036.67% to -$5.1 million in 2022, then skyrocketed by 105.83% to $298000.0 in 2023, then soared by 1235.91% to $4.0 million in 2024, then dropped by 8.54% to $3.6 million in 2025.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods came in at $3.6 million, -$1.8 million, and $904000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.